S217: PRELIMINARY ANALYSIS OF THE PHASE II STUDY USING TOLINAPANT (ASTX660) MONOTHERAPY IN 98 PERIPHERAL T-CELL LYMPHOMA AND 51 CUTANEOUS T-CELL LYMPHOMA SUBJECTS WITH RELAPSED REFRACTORY DISEASE. (23rd June 2022) - Michot, J.-M.; Mehta, A.; Samaniego, F.; Bachy, E.; Zinzani, P. L.; Prica, A.; Colins, G. P.; Ribrag, V; Wagner-Johnston, N.; El-Sharkawi, D.; O'Connor, O. A.; Wilcox, R.; et al.